Loading...
Expression of ADAM Proteases in Bladder Cancer Patients with BCG Failure: A Pilot Study
Although Bacillus Calmette Guérin (BCG) remains a mainstay of adjuvant treatment in high-risk, non-muscle-invasive bladder cancer, BCG failure occurs in up to 40% of patients, with radical cystectomy (RC) as the inevitable therapeutic consequence. Current data suggest that PD-L1 immunosuppressive si...
Na minha lista:
| Udgivet i: | J Clin Med |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7917772/ https://ncbi.nlm.nih.gov/pubmed/33672843 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10040764 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|